Search Results - "Griskevicius, Laimonas"

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study by Maneikis, Kazimieras, Šablauskas, Karolis, Ringelevičiūtė, Ugnė, Vaitekėnaitė, Vilmantė, Čekauskienė, Rita, Kryžauskaitė, Lina, Naumovas, Daniel, Banys, Valdas, Pečeliūnas, Valdas, Beinortas, Tumas, Griškevičius, Laimonas

“…Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2…”
Get full text

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients by Spyridonidis, Alexandros, Labopin, Myriam, Savani, Bipin N., Niittyvuopio, Riitta, Blaise, Didier, Craddock, Charles, Socié, Gerard, Platzbecker, Uwe, Beelen, Dietrich, Milpied, Noel, Cornelissen, Jan J., Ganser, Arnold, Huynh, Anne, Griskevicius, Laimonas, Giebel, Sebastian, Aljurf, Mahmoud, Brissot, Eolia, Malard, Florent, Esteve, Jordi, Peric, Zinaida, Baron, Frédéric, Ruggeri, Annalisa, Schmid, Christoph, Gilleece, Maria, Gorin, Norbert-Claude, Lanza, Francesco, Shouval, Roni, Versluis, Jurjen, Bug, Gesine, Fløisand, Yngvar, Ciceri, Fabio, Sanz, Jamie, Bazarbachi, Ali, Nagler, Arnon, Mohty, Mohamad

“…To address limitations of the currently used reduced-intensity/myeloablative conditioning (RIC/MAC) classification scheme we aimed to develop a tool that can…”
Get full text

Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial by CORTES, Jorge E, KIM, Dong-Wook, GAMBACORTI-PASSERINI, Carlo, KANTARJIAN, Hagop M, BRÜMMENDORF, Tim H, DYAGIL, Irina, GRISKEVICIUS, Laimonas, MALHOTRA, Hemant, POWELL, Christine, GOGAT, Karin, COUNTOURIOTIS, Athena M

“…Bosutinib is an oral Src/Abl tyrosine kinase inhibitor. The phase III Bosutinib Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia (BELA) trial…”
Get full text

Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation by Zucenka, Andrius, Vaitekenaite, Vilmante, Maneikis, Kazimieras, Davainis, Linas, Pileckyte, Regina, Trociukas, Igoris, Peceliunas, Valdas, Zvirblis, Tadas, Staras, Vytautas, Griskevicius, Laimonas

“…We retrospectively compared the outcomes of 20 patients receiving Venetoclax + low-dose Cytarabine + Actinomycin D (ACTIVE) with 29 patients receiving FLAG-Ida…”
Get full text

Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions by Dudas, Gytis, Hong, Samuel L., Potter, Barney I., Calvignac-Spencer, Sébastien, Niatou-Singa, Frédéric S., Tombolomako, Thais B., Fuh-Neba, Terence, Vickos, Ulrich, Ulrich, Markus, Leendertz, Fabian H., Khan, Kamran, Huber, Carmen, Watts, Alexander, Olendraitė, Ingrida, Snijder, Joost, Wijnant, Kim N., Bonvin, Alexandre M.J.J., Martres, Pascale, Behillil, Sylvie, Ayouba, Ahidjo, Maidadi, Martin Foudi, Djomsi, Dowbiss Meta, Godwe, Celestin, Butel, Christelle, Šimaitis, Aistis, Gabrielaitė, Miglė, Katėnaitė, Monika, Norvilas, Rimvydas, Raugaitė, Ligita, Koyaweda, Giscard Wilfried, Kandou, Jephté Kaleb, Jonikas, Rimvydas, Nasvytienė, Inga, Žemeckienė, Živilė, Gečys, Dovydas, Tamušauskaitė, Kamilė, Norkienė, Milda, Vasiliūnaitė, Emilija, Žiogienė, Danguolė, Timinskas, Albertas, Šukys, Marius, Šarauskas, Mantas, Alzbutas, Gediminas, Aziza, Adrienne Amuri, Lusamaki, Eddy Kinganda, Cigolo, Jean-Claude Makangara, Mawete, Francisca Muyembe, Lofiko, Emmanuel Lokilo, Kingebeni, Placide Mbala, Tamfum, Jean-Jacques Muyembe, Belizaire, Marie Roseline Darnycka, Essomba, René Ghislain, Assoumou, Marie Claire Okomo, Mboringong, Akenji Blaise, Dieng, Alle Baba, Juozapaitė, Dovilė, Hosch, Salome, Obama, Justino, Ayekaba, Mitoha Ondo’o, Naumovas, Daniel, Pautienius, Arnoldas, Rafaï, Clotaire Donatien, Vitkauskienė, Astra, Ugenskienė, Rasa, Gedvilaitė, Alma, Čereškevičius, Darius, Lesauskaitė, Vaiva, Žemaitis, Lukas, Griškevičius, Laimonas, Baele, Guy

“…Distinct SARS-CoV-2 lineages, discovered through various genomic surveillance initiatives, have emerged during the pandemic following unprecedented reductions…”
Get full text

Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease by Danylesko, Ivetta, Bukauskas, Adomas, Paulson, Martin, Peceliunas, Valdas, Gedde-Dahl d.y, Tobias, Shimoni, Avichai, Shouval, Roni, Griskevicius, Laimonas, Floisand, Yngvar, Nagler, Arnon

“…Steroid-resistant (SR) acute graft-versus-host disease (aGvHD) is a life-threatening complication of allogeneic stem cell transplantation. Vedolizumab is a…”
Get full text

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia by Pfirrmann, Markus, Clark, Richard E., Prejzner, Witold, Lauseker, Michael, Baccarani, Michele, Saussele, Susanne, Guilhot, François, Heibl, Sonja, Hehlmann, Rüdiger, Faber, Edgar, Turkina, Anna, Ossenkoppele, Gert, Höglund, Martin, Zaritskey, Andrey, Griskevicius, Laimonas, Olsson-Strömberg, Ulla, Everaus, Hele, Koskenvesa, Perttu, Labar, Boris, Sacha, Tomasz, Zackova, Daniela, Cervantes, Francisco, Colita, Adriana, Zupan, Irena, Bogdanovic, Andrija, Castagnetti, Fausto, Guilhot, Joëlle, Hasford, Joerg, Hochhaus, Andreas, Hoffmann, Verena S.

“…Prognostic scores support clinicians in selecting risk-adjusted treatments and in comparatively assessing different results. For patients with chronic-phase…”
Get full text

Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age by Rank, Cecilie U, Wolthers, Benjamin O, Grell, Kathrine, Albertsen, Birgitte K, Frandsen, Thomas L, Overgaard, Ulrik M, Toft, Nina, Nielsen, Ove J, Wehner, Peder S, Harila-Saari, Arja, Heyman, Mats M, Malmros, Johan, Abrahamsson, Jonas, Norén-Nyström, Ulrika, Tomaszewska-Toporska, Beata, Lund, Bendik, Jarvis, Kirsten B, Quist-Paulsen, Petter, Vaitkevičienė, Goda E, Griškevičius, Laimonas, Taskinen, Mervi, Wartiovaara-Kautto, Ulla, Lepik, Kristi, Punab, Mari, Jónsson, Ólafur G, Schmiegelow, Kjeld

“…Asparaginase-associated pancreatitis (AAP) is common in patients with acute lymphoblastic leukemia (ALL), but risk differences across age groups both in…”
Get full text

Oxidative phosphorylation inhibition induces anticancerous changes in therapy‐resistant–acute myeloid leukemia patient cells by Vitkevičienė, Aida, Janulis, Vytautas, Žučenka, Andrius, Borutinskaitė, Veronika, Kaupinis, Algirdas, Valius, Mindaugas, Griškevičius, Laimonas, Navakauskienė, Rūta

“…Treatment of acute myeloid leukemia (AML) is still a challenge because of common relapses or resistance to treatment. Therefore, the development of new…”
Get full text

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin by Baron, Frédéric, Galimard, Jacques-Emmanue, Labopin, Myriam, Yakoub-Agha, Ibrahim, Niittyvuopio, Riitta, Kröger, Nicolaus, Griskevicius, Laimonas, Wu, Depei, Forcade, Edouard, Richard, Carlos, Aljurf, Mahmoud, Helbig, Grzegorz, Labussière-Wallet, Hélène, Mohty, Mohamad, Nagler, Arnon

“…We compared severe graft- -host-disease (GvHD) free and relapse-free survival and other transplantation outcomes of acute myeloid leukemia (AML) patients given…”
Get full text

Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach - a population-based study by Norvilas, Rimvydas, Dirse, Vaidas, Semaskeviciene, Ruta, Mickeviciute, Orinta, Gineikiene, Egle, Stoskus, Mindaugas, Vaitkeviciene, Goda, Rascon, Jelena, Griskevicius, Laimonas

“…ABL-class and JAK-STAT signaling pathway activating alterations have been associated with both a poor post-induction minimal residual disease (MRD) response…”
Get full text

Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients by Zucenka, Andrius, Maneikis, Kazimieras, Pugaciute, Birute, Ringeleviciute, Ugne, Dapkeviciute, Austeja, Davainis, Linas, Daukelaite, Guoda, Burzdikaite, Paulina, Staras, Vytautas, Griskevicius, Laimonas

“…We retrospectively collected clinical data on 31 relapsed or refractory acute myeloid leukemia (R/R AML) patients who were treated with outpatient glasdegib…”
Get full text

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival by Tettero, Jesse M, Ngai, Lok Lam, Bachas, Costa, Breems, Dimitri A, Fischer, Thomas, Gjertsen, Bjorn T, Gradowska, Patrycja, Griskevicius, Laimonas, Janssen, Jeroen J W M, Juliusson, Gunnar, Maertens, Johan, Manz, Markus G, Pabst, Thomas, Passweg, Jakob, Porkka, Kimmo, Valk, Peter J M, Löwenberg, Bob, Ossenkoppele, Gert J, Cloos, Jacqueline

Get full text

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors by Brissot, Eolia, Labopin, Myriam, Moiseev, Ian, Cornelissen, J J, Meijer, Ellen, Van Gorkom, Gwendolyn, Rovira, Montserrat, Ciceri, Fabio, Griskevicius, Laimonas, Blaise, Didier, Forcade, Edouard, Mistrik, Martin, Mielke, Stephan, Bulabois, Claude Eric, Niittyvuopio, Riitta, Deconinck, Eric, Ruggeri, Annalisa, Sanz, Jaime, Spyridonidis, Alexandros, Savani, Bipin, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad

“…Graft-versus-host disease (GVHD) remains a major contributor to mortality and morbidity after allogeneic stem-cell transplantation (allo-HSCT). The updated…”
Get full text

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria by Nishimura, Jun-Ichi, Ando, Kiyoshi, Masuko, Masayoshi, Noji, Hideyoshi, Ito, Yoshikazu, Mayer, Jiri, Griskevicius, Laimonas, Bucher, Christoph, Müllershausen, Florian, Gergely, Peter, Rozenberg, Izabela, Schubart, Anna, Chawla, Raghav, Rondeau, Jean-Michel, Roguska, Michael, Splawski, Igor, Keating, Mark T, Johnson, Leslie, Danekula, Rambabu, Bagger, Morten, Watanabe, Yoko, Haraldsson, Börje, Kanakura, Yuzuru

Get full text

Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial by Ngai, Lok Lam, Hanekamp, Diana, Janssen, Fleur, Carbaat-Ham, Jannemieke, Hofland, Maaike A. M. A., Fayed, Mona M. H. E, Kelder, Angèle, Oudshoorn-van Marsbergen, Laura, Scholten, Willemijn J., Snel, Alexander N., Bachas, Costa, Tettero, Jesse M., Breems, Dimitri A., Fischer, Thomas, Gjertsen, Bjørn T., Griškevičius, Laimonas, Juliusson, Gunnar, van de Loosdrecht, Arjan A., Maertens, Johan A., Manz, Markus G., Pabst, Thomas, Passweg, Jakob R., Porkka, Kimmo, Valk, Peter J. M., Gradowska, Patrycja, Löwenberg, Bob, de Leeuw, David C., Janssen, Jeroen J. W. M., Ossenkoppele, Gert J., Cloos, Jacqueline

“…[Display omitted]…”
Get full text

Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT by Nagler, Arnon, Labopin, Myriam, Mielke, Stephan, Passweg, Jakob, Blaise, Didier, Gedde-Dahl, Tobias, Cornelissen, Jan J., Salmenniemi, Urpu, Yakoub-Agha, Ibrahim, Reményi, Péter, Socié, Gerard, van Gorkom, Gwendolyn, Labussière-Wallet, Hélène, Huang, Xiao-Jun, Rubio, Marie Thérèse, Byrne, Jenny, Craddock, Charles, Griškevičius, Laimonas, Ciceri, Fabio, Mohty, Mohamad

“…We compared transplants (HSCT) from matched related siblings (MSD) with those from matched 10/10 and mismatched 9/10 unrelated (UD) and T-replete…”
Get full text

Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study by Boissel, Nicolas, Chevallier, Patrice, Doronin, Vadim, Griskevicius, Laimonas, Maschan, Alexey, McCloskey, James, Rambaldi, Alessandro, Rossi, Giuseppe, Sokolov, Andrey, Wartiovaara‐Kautto, Ulla, Oprea, Corina, Abbadessa, Giovanni, Gosselin, Alice, Macé, Sandrine, Thomas, Xavier

“…The poor prognosis of acute T‐cell lymphoblastic leukemia (T‐ALL) and T‐cell lymphoblastic lymphoma (T‐LBL) in older adults and patients with…”
Get full text

Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013 by Beinortas, Tumas, Tavorienė, Ilma, Žvirblis, Tadas, Gerbutavičius, Rolandas, Jurgutis, Mindaugas, Griškevičius, Laimonas

“…Currently available chronic myeloid leukaemia (CML) survival reports have originated from more affluent countries. Herein we report the entire country data on…”
Get full text

Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia by Pileckyte, Regina, Valceckiene, Vilma, Stoskus, Mindaugas, Matuzeviciene, Reda, Sejoniene, Jurgita, Zvirblis, Tadas, Griskevicius, Laimonas

“…: BTK and BCL2 inhibitors have changed the treatment paradigms of high-risk and elderly patients with chronic lymphocytic leukemia (CLL), but their long-term…”
Get full text